# Tiburio Therapeutics Inc. — Form D

Tiburio Therapeutics Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-01-08. The offering totals $31.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2019-01-08
- Form: D
- Accession: 0001763894-19-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $31.0M
- Amount sold: $5.0M
- Remaining: $26.0M
- Investors: 5
- Date of first sale: 2018-12-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-329946

## Issuer

- Name: Tiburio Therapeutics Inc.
- CIK: 0001763894
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 700 TECHNOLOGY SQUARE, CAMBRIDGE, MA, 02139
- Phone: 617-231-6020

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Christoph M Adams | Director | CAMBRIDGE, MA |
| Sandip Kirstine Agarwala | Director | Cambridge, MA |
| Mette Kirstine Agger | Director | CAMBRIDGE, MA |
| David Kirstine Mott | Director | Cambridge, MA |
| Sara Kirstine Nayeem | Director | Cambridge, MA |
| Christoph M Adams | Executive Officer | CAMBRIDGE, MA |
| Abraham N Ceesay | Executive Officer | Cambridge, MA |
| James G McArthur | Executive Officer | CAMBRIDGE, MA |

## More

- [CIK 1763894 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1763894&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001763894-19-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.